国外医药(抗生素分册)2024,Vol.45Issue(3) :145-153.

抗菌肽的设计与临床研究策略

Design and Clinical Research Strategies of Antimicrobial Peptides

刘艳超 孙欣 马天玥 郑珩
国外医药(抗生素分册)2024,Vol.45Issue(3) :145-153.

抗菌肽的设计与临床研究策略

Design and Clinical Research Strategies of Antimicrobial Peptides

刘艳超 1孙欣 1马天玥 1郑珩1
扫码查看

作者信息

  • 1. 中国药科大学生命科学与技术学院,南京 211100
  • 折叠

摘要

抗生素耐药性问题严重威胁着人类健康,是全球公共卫生安全的主要威胁之一.具有广谱抗菌活性、多样杀菌机制的抗菌肽作为近年来的研究热点,被认为是极具潜力的抗生素替代品.目前已有部分抗菌肽正在进行用于预防和治疗细菌病原体感染的临床试验,然而,较低的生物利用度及溶血活性等可能存在的毒副作用给天然抗菌肽的临床转化带来了障碍.因此,通过介绍抗菌肽在临床上的研究进展,并总结抗菌肽药物开发过程中的挑战及开发策略,以期为抗菌肽的药物开发提供新的思路.

Abstract

Antimicrobial resistance is a serious threat to human health and global public health security.Antimicrobial peptides,which have garnered significant attention recently due to their broad-spectrum antibacterial activity and varied bactericidal processes,are being regarded as viable substitutes for antibiotics.At present,some antimicrobial peptides are undergoing clinical trials for the prevention and treatment of bacterial pathogen infections.Nevertheless,low bioavailability and significant hemolytic activity,two potentially harmful side effects,prevented antimicrobial peptides from being clinically converted.In order to provide new ideas for the drug development of antimicrobial peptides,this article introduces the research progress of antimicrobial peptides in clinical,summarizes the challenges during the drug development and provides some strategies for its development.

关键词

抗菌肽/临床进展/抗菌药物/抗菌机制/优化改造/细菌耐药性

Key words

antimicrobial peptides/clinical application/antimicrobial drugs/antibacterial mechanism/optimization and renovation/antimicrobial resistance

引用本文复制引用

基金项目

国家自然科学基金(82073767)

出版年

2024
国外医药(抗生素分册)
中国医药集团总公司四川抗菌素工业研究所,中国医学科学院医药生物技术研究所

国外医药(抗生素分册)

影响因子:0.852
ISSN:1001-8751
参考文献量60
段落导航相关论文